Manufacturing and supplying pharmaceutical medicines in various therapeutic segments.
Annual revenue $335,663 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Nark Pharmaceuticals

Nark Pharmaceuticals is a company. Nark Pharmaceuticals offers products and services including Medicines and Supply Chain Services.

Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $335.66 K (USD)
    24.12
    as on Mar 31, 2022
  • Net Profit
    $11.09 K (USD)
    -55.58
    as on Mar 31, 2022
  • EBITDA
    $18.2 K (USD)
    -42.91
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Nark Pharmaceuticals

Nark Pharmaceuticals offers a comprehensive portfolio of products and services, including Medicines and Supply Chain Services.

Product name locked
Category locked
Primary

High quality effective and affordable medicines are provided for a wide spectrum of chronic and acute treatments

Product name locked
Category locked
Locked

An effective supply chain network is established to meet the demands of a fast-evolving marketplace

Funding Insights of Nark Pharmaceuticals

Premium access

Detailed funding history for Nark Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Nark Pharmaceuticals

Investments
Premium access

Investment portfolio details for Nark Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Nark Pharmaceuticals

Premium access

Detailed financials for Nark Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Nark Pharmaceuticals Comparisons

Nark Pharmaceuticals Primary company
Description
Manufacturing and supplying pharmaceutical medicines in vari...
Location
-
Founded Year
-
Annual Revenue
$335.66 K (USD)
Net Profit
$11.09 K (USD)
EBITDA
$18.2 K (USD)
Employees
Not available
Premium access

Peer comparison for Nark Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Nark Pharmaceuticals

Premium access

Detailed competitors of Nark Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Nark Pharmaceuticals

Premium access

Complete news archive for Nark Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nark Pharmaceuticals

Annual revenue of Nark Pharmaceuticals is $335.66K as on Mar 31, 2022.

Nark Pharmaceuticals is identified as a leading Indian pharmaceutical company that focuses on the availability of high-quality, effective, and affordable medicines for a broad range of illnesses, including chronic and acute treatments in segments like cardiology and neurology. Global standards of quality in drug manufacturing are upheld, alongside the development of an effective supply chain network. Digitization is utilized to enhance business operations, while a trained marketing team is driven to improve patients lives. Commitment is shown to promoting womens participation in the workplace, with over a decade of experience aimed at making a positive difference for patients, customers, and communities.

Nark Pharmaceuticals offers Medicines and Supply Chain Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available